Clinical Trials Directory

Trials / Unknown

UnknownNCT03466541

Workplace Interventions Preventing Risky Use of Alcohol and Sick Leave

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
500 (estimated)
Sponsor
University of Stavanger · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The aim of this study is to investigate the effectiveness of two workplace interventions (the Riskbruk model and Balance) in reducing risky alcohol consumption, sickness absence and presenteeism. The purpose is to assess whether the Riskbruk model should be implemented in the Norwegian workforce in its entirety, whether the less extensive and costly alternative Balance is sufficient, or if neither one of them show effectiveness compared to usual care.

Conditions

Interventions

TypeNameDescription
BEHAVIORALRiskbrukThe Riskbruk model incorporates alcohol screening through a widely employed alcohol screening questionnaire, the Alcohol Use Disorders Identification Test (AUDIT) and a standard alcohol biomarker, carbohydrate-deficient transferring in serum (CDT), with brief consultations using the motivational interviewing (MI) technique. MI is a collaborative conversation style used to increase awareness and reflection around one's own drinking habits, as well as strengthening the person's motivation for a lifestyle change. The conversation style includes expressing empathy through reflective listening, communicating respect and acceptance of the participants and their feelings, and open up for self-reflection and exploration around the drinking behaviour.
BEHAVIORALBalanceBalance is a new Norwegian eHealth programme, and incorporates two approaches to behaviour modification interventions: a brief interventions and an intensive self-help programme. The intervention is based on cognitive-behavioural and self-help principles, and is given to the participants through multiple interactive sessions.

Timeline

Start date
2013-08-01
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2018-03-15
Last updated
2022-11-28

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT03466541. Inclusion in this directory is not an endorsement.